FDA Factory Approval and Relaunch of Aridol in US Market
15th
Aug 18
Release Date: 15/08/2018 9:15am
Pharmaceutical research company Pharmaxis (ASX: PXS) today announced the company has received approval from the United States Food and Drug Administration (FDA) for its manufacturing facility to produce the asthma diagnostic product Aridol for the US market.
Categories: News and Media